|1.||Yim, Hyung Joon: 8 articles (10/2015 - 12/2009)|
|2.||Byun, Kwan Soo: 8 articles (11/2014 - 08/2007)|
|3.||Ahn, Sang Hoon: 8 articles (11/2014 - 11/2007)|
|4.||Kwon, So Young: 8 articles (09/2014 - 07/2008)|
|5.||Marcellin, Patrick: 8 articles (04/2014 - 12/2005)|
|6.||Hong, Sun Pyo: 8 articles (01/2014 - 03/2008)|
|7.||Lee, Chang Hong: 8 articles (09/2013 - 08/2007)|
|8.||Seo, Yeon Seok: 7 articles (10/2015 - 08/2007)|
|9.||Kim, Ji Hoon: 7 articles (10/2015 - 08/2007)|
|10.||Yeon, Jong Eun: 7 articles (11/2014 - 08/2007)|
|1.||Chronic Hepatitis B
02/01/2013 - "Sustained efficacy of adefovir add-on therapy in chronic hepatitis B patient with a poor virological response to peginterferon alfa."
01/01/2004 - "Adefovir 10 mg/d orally is safe and effective for treatment of chronic hepatitis B."
04/01/2013 - "Chronic hepatitis B clinic patients from a tertiary hospital on adefovir treatment, with their clinical and laboratory parameters were extracted from the hospital electronic clinical database in an observational study design. "
05/01/2008 - "The aims of the present study were to assess initial virological response (IVR) to adefovir (ADV) treatment for chronic hepatitis B, to identify patients with suboptimal response and to determine the incidence of ADV-resistant mutants. "
02/21/2015 - "Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B."
10/01/2014 - "Adefovir was effective in replicative HBV infection in Bangladeshi population. "
05/01/1995 - "Efficacy of 9-(2-phosphonylmethoxyethyl)adenine treatment against chronic simian immunodeficiency virus infection in macaques."
01/01/2013 - "ChiCTR-TRC-11001263 study was the first large-scale double-blind randomized placebo-controlled traditional Chinese medicines (TCMs) and adefovir (ADV) antihepatitis B virus (HBV) infection trial in the world. "
12/01/2005 - "The aim of this study was to describe the clinical course of patients with adefovir-resistant HBV infection. "
03/01/2005 - "In this study, we analyzed the therapeutic effect of adefovir for recurrent or de novo HBV infection after LT. "
01/01/2015 - "In patients with hepatitis B-related HCC, adefovir antiviral therapy reduced late HCC recurrence and significantly improved overall survival after R0 hepatic resection."
04/01/2015 - "In patients whose hepatitis B reactivated, adefovir was associated with a lower resistance profile."
05/01/2010 - "111 (69.4 %) of all patients received a hepatitis B specific treatment at the time they were interviewed, most of them adefovir (41.5 %) or lamivudin (35.4 %) alone. "
12/01/2008 - "Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers."
11/01/2008 - "Adefovir (9-(2-phosphonomethoxyethyl)adenine) is an acyclic nucleoside phosphonate currently used for the treatment of hepatitis B. "
07/01/2011 - "Increased compared to stable/decreased total apoptotic trend [D-apoptosis: (D-bax)-(D-bcl-xL)], was associated with worsening fibrosis, particularly in adefovir treated patients (D-stage: 2.3 vs. 0, P = 0.004). "
02/01/2011 - "Cirrhosis was a significant risk factor for adefovir resistance. "
02/01/2010 - "HCC developed more frequently in the patients with than without cirrhosis at the start of adefovir (10/59 [16.9%] vs. 8/188 [4.3%], P = 0.002). "
09/01/2006 - "This is the first reported case of some beneficial biochemical and serologic effects of adefovir dipivoxyl in the treatment of delta cirrhosis. "
10/20/2015 - "To compare the efficacies ofentecavir and adefovir in patients with chronic hepatitis B (CHB) and cirrhosis when administered as monotherapies using a 240-week course. "
|5.||Liver Cirrhosis (Hepatic Cirrhosis)
09/01/2006 - "Adefovir dipivoxyl for the treatment of delta-related liver cirrhosis."
09/01/2006 - "Given the positive outcome, this report suggests that adefovir might be beneficial in patients with delta-related liver cirrhosis not responsive to previous lamivudine therapy. "
06/01/2014 - "Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus."
09/01/2006 - "To report a case suggesting the beneficial effect of adefovir dipivoxyl in patients with delta-related decompensated liver cirrhosis ineffectively treated with lamivudine. "
04/01/2006 - "Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis."
|5.||Hepatitis B e Antigens
|7.||adefovir dipivoxil (Hepsera)
|8.||Interferon-alpha (Interferon Alfa)
|3.||Transplantation (Transplant Recipients)
|5.||Drug Therapy (Chemotherapy)